ADVERTISEMENT
970x220
.navbar-nav.header-menu { width: 100%; justify-content: center; } .tab-menu-outers .nav-item{ width: unset; } .tab-bar-social.mt-5 { margin-top: 0 !important; } .second-header-menu { margin-top: 27px; padding: 12px 0; border-top: 1px solid #C3C1AE; border-bottom: 1px solid #C3C1AE; } .third-header-menu{ padding: 12px 0; } .bottom-header-menu { margin-right: 25px; text-decoration: none; font-family: "Canicule Display v0.3 Trial" , serif; font-weight: 500; font-size: 15px; line-height: 16px; color: black; } .bottom-header-menu:hover { color: #0A58CA !important; } header .time-date-section { display: flex; align-items: end; } header .mb-header-center .align-items-center .col-3 , header .mb-header-center .align-items-center .col-6, header .top-header-container .col-md-6{ z-index: 100; } header .desktop-menu-bar li:hover a{ background: transparent; color: #2E3192 !important; } @media(max-width: 767px) { header.header.mb-header{ display:none; } .second-header-menu .justify-content-center{ justify-content: start !important; } .second-header-menu ul , .third-header-menu ul{ display: grid; grid-template-columns: 1fr 1fr; width: 100%; } }

Unveiling the magic of biostimulators

How Sculptra, Aesthefill, and Ultracol can lead to youthful skin

Published Sep 29, 2024 08:04 am  |  Updated Sep 29, 2024 08:04 am

At A Glance

  • While Sculptra, Aesthefill, and Ultracol differ in their specifics, they share crucial benefits that have proven attractive.

IMG_4163.JPG

In the quest for youthful skin, biostimulators have emerged as a popular solution. Among the most talked-about options in the Philippines are Sculptra, Aesthefill, and Ultracol. Although they share the common goal of rejuvenating tired skin, they each possess unique characteristics. Here, we delve into what sets these innovative treatments apart and their collective benefits.

 

I.  Sculptra: The long-lasting PLLA wonder

Sculptra is a renowned dermal filler primarily composed of poly-L-lactic acid. Unlike traditional fillers that provide immediate volume, Sculptra works by gradually stimulating collagen production. This process can take multiple sessions over a few months, subtly improving skin texture and elasticity. Its most notable advantage is the longevity of results, often lasting up to two years. However, patience is required as the transformation is not instant and depends on the body's natural collagen production response. Typically, patients undergo two to three treatment sessions per year, with each session spaced four to six weeks apart. This interval ensures optimal collagen production, leading to a gradual yet lasting improvement in skin texture and volume.

 

II.  Aesthefill: PDLLA for remarkable durability

Aesthefill also utilizes poly-L-lactic acid but is designed with a unique formulation to offer a natural-looking rejuvenation. It similarly stimulates collagen production but tends to provide faster results compared to Sculptra. Patients often notice improvements within a few weeks. Aesthefill is ideal for those seeking a balance between immediate effect and long-term benefit without compromising on the natural feel and appearance of their skin. It usually lasts around 18 months, making it a favorable option for medium-term skin revitalization. The interval between sessions mirrors that of Sculptra—consistent two to three sessions annually, spaced four to six weeks apart. This regimen assists in maintaining a continuous, natural-looking improvement.

 

III.  Ultracol: The PDO champion for short-term needs

Ultracol sets itself apart as the first polydioxanone (PDO) filler featuring spherical PDO microparticles. PDO, known as the safest biodegradable suture material with low tissue reactivity, serves as a foundation for Ultracol's impressive capabilities.

Ultracol differs markedly in both composition and duration. Crafted from Polydioxanone (PDO), its particles are noticeably larger, with sizes ranging from 50 to 110 um. The key difference is its comparatively brief effective period, lasting just 3 to 6 months. Consequently, treatment intervals are more frequent, occurring every three to four months. Despite its shorter lifespan, Ultracol’s quick results make it an excellent choice for those seeking immediate albeit temporary skin enhancements.

 

Common grounds: The shared benefits

While Sculptra, Aesthefill, and Ultracol differ in their specifics, they share crucial benefits that have proven attractive:

Collagen Production:  All three treatments stimulate the body’s natural collagen production, leading to an organic improvement in skin quality.

Minimally Invasive:  These biostimulators require no surgical intervention, making them a safer, less daunting option compared to more invasive procedures.

Gradual Improvement:  Each treatment offers a subtle, gradual enhancement, allowing for a more natural-looking result over time.

Versatility:  Suitable for varying skin types and issues, these treatments can be tailored to individual needs and concerns.

 

Choosing between Sculptra, Aesthefill, and Ultracol depends largely on individual needs and expectations. For those seeking long-term results with fewer appointments, Sculptra or Aesthefill may be ideal. Conversely, individuals needing quick, short-term solutions may find Ultracol to be a better fit.

 

Before making a decision, consultation with a qualified dermatologist or cosmetic surgeon is essential. Personal factors such as skin type, age, and specific skin concerns should guide the choice of treatment.

 

Ultimately, whether it’s the long-lasting effects of PLLA and PDLLA, or the immediate but temporary results of PDO, these biostimulators offer exciting opportunities to maintain youthful, vibrant skin.

 

Embrace the science behind biostimulators, and choose the one that best aligns with your aesthetic goals. Your journey to rejuvenated skin is just a treatment away.

 

Related Tags

Dr. Kaycee Reyes Lifestyle Health and Wellbeing
ADVERTISEMENT
300x250
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0 72px 0 12px; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // The two offset values // changed to 10 from 1 , 2 const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } function isNearBottom() { return window.innerHeight + window.scrollY >= document.documentElement.scrollHeight - 100; } function onScroll() { if (isLoading) return; // Skip if already loading if (isNearBottom()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; // Set flag to prevent multiple calls const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { loadCount++; // Increment only after successful execution }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; // Reset flag after execution }); } } window.addEventListener("scroll", onScroll); }); // Mutation Observer for Newly Loaded Articles const observer = new MutationObserver(() => { const articles = document.querySelectorAll(".articles-observe"); if (articles.length > 0) { observeArticles(articles); } }); observer.observe(document.body, { childList: true, subtree: true }); // Intersection Observer for Updating URL function observeArticles(articles) { const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); } } }); }, { threshold: 0.1 } ); articles.forEach(article => intersectionObserver.observe(article)); }
.col-md-12.noPadding.col-xs-12:has(.mb-header-bottom) {padding: 0;} .bottom-footer {color: #fff;background-color: #2E3192;padding: 8px 0;} .bottom-footer .bottom-footer-menu {font-family: Inter;font-weight: 400;font-size: 12px;line-height: 16px;padding: 0px 10px !important;color: #fff !important;text-decoration: none; } .bottom-footer .container {display: flex;justify-content: space-between;align-items: center; } .bottom-footer p{font-family: "Inter";font-weight: 400;font-size: 12px;line-height: 16px;margin-bottom: 0;} .subscribe-button{position: absolute;bottom: 15%;right: 11%;} .subscribe-container {position: fixed;display: flex;align-items: center;background-color: white;height: 50px;border-radius: 50px;box-shadow: 1px 3px 8px 3px rgba(0, 0, 0, 0.2);width: 50px;overflow: hidden;transition: width 0.3s ease-in-out;text-decoration: none;white-space: nowrap; } .subscribe-icon {background-color: #2E3192;color: white;border-radius: 50%;width: 50px;height: 50px;display: flex;align-items: center;justify-content: center;font-size: 18px;flex-shrink: 0;transition: border-radius 0.3s ease-in-out; } .subscribe-text {font-size: 18px;font-weight: bold;color: black;margin-left: 0;margin-right: 0;width: 0;visibility: hidden;opacity: 0;transition: opacity 0.3s ease, width 0.3s ease;} .subscribe-container:hover {cursor: pointer;width: 170px;} .subscribe-container:hover .subscribe-icon {border-bottom-right-radius: 0;border-top-right-radius: 0;} .subscribe-container:hover .subscribe-text {visibility: visible;opacity: 1;margin-left: 10px;margin-right: 10px;width: auto;} h6.footer-heading{ font-weight: 700; } #bottom-footer ul li { display: flex; align-items: center; } @media screen and (min-width: 767px) and (max-width: 991px) { .bottom-footer p, .bottom-footer .bottom-footer-menu{ font-size: 9px; } } @media(max-width: 767px) { .bottom-footer .container {display: block;} .bottom-footer .container .justify-content-center{margin-top: 20px !important;} .bottom-footer .container .justify-content-center .list-group{ width: 100%; display: grid; row-gap: 10px; grid-template-columns: 1fr 1fr 1fr; justify-content: unset; } .bottom-footer p{font-size: 10px;} .subscribe-container { width: 50px !important; overflow: hidden;} .subscribe-container:hover { width: 50px !important;} .subscribe-container .subscribe-text {display: none !important;} .subscribe-button{right: 15%;bottom:7%;} } .mb-header-bottom .header-menu:hover { color: #2E3192 !important; } @media(max-width: 400px) { .bottom-footer .container .justify-content-center .list-group{ grid-template-columns: 1fr 1fr; } }

Sign up by email to receive news.